March 2018, Vol. 108, (3 Suppl 1)
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...n randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
more
Strengthening Community responses to HIv Treatment and Prevention
Vision 2030
Accessed: 17.11.2019
It's time to deliver differently.
Accessed: 13.11.2019
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
Technical Report
AIDS Medicines and diagnostics service
September 2016
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
“Continuum of HIV services refers to a comprehensive package of HIV prevention, diagnostic, treatment, care and support services provided for people at risk of HIV infection or living with HIV and their families”
August, 2018